| Literature DB >> 30250463 |
Gaëlle Carré1, Emilie Charpentier1,2, Sandra Audonnet3,4, Christine Terryn4, Mohamed Boudifa5, Christelle Doliwa1, Zouhaier Ben Belgacem1, Sophie C Gangloff1,2, Marie-Paule Gelle1,6,7.
Abstract
We have recently developed a non-thermal plasma (NTP) equipment intended to sterilize fragile medical devices and maintain the sterile state of items downstream the treatment. With traditional counts on agar plate a six log reduction of Staphylococcus aureus viability was obtained within 120 min of O2, Ar, or N2 NTP treatments. However to determine the best NTP process, we studied the different physiological states of S. aureus by flow cytometry (FC) and confocal laser scanning microscopy (CLSM) focusing on the esterasic activity and membrane integrity of the bacteria. Two fluorochromes, 5-(and-6)-carboxy-2',7'-dichlorofluorescein diacetate and propidium iodide were used in order to distinguish three sub-populations: metabolically active, permeabilized, and damaged bacteria that can be in the viable but nonculturable state. FC and CLSM highlight that O2 and Ar NTP treatments were the most attractive processes. Indeed, a 5 min of Ar NTP generated a high destruction of the structure of bacteria and a 120 min of O2 NTP treatment led to the higher decrease of the total damaged bacteria population. SEM observations showed that in presence of clusters, bacteria of upper layers are easily altered compared to bacteria in the deeper layers. In conclusion, the plate counting method is not sufficient by itself to determine the best NTP treatment. FC and CLSM represent attractive indicator techniques to select the most efficient gas NTP treatment generating the lowest proportion of viable bacteria and the most debris.Entities:
Keywords: Staphylococcus aureus; confocal microscopy; flow cytometry; fluorescence; non-thermal plasma
Year: 2018 PMID: 30250463 PMCID: PMC6140754 DOI: 10.3389/fmicb.2018.02171
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Analyse by FC of Staphylococcus aureus sub-populations [total labeled, metabolically active sub-population (DCFDA+ and PI-), damaged sub-population (DCFDA+ and PI+), and permeabilized sub-population (DCFDA- and PI+)] labeled with PI and DCFDA fluorochromes after 5 and 15 min of O2, Ar, and N2 NTP treatments.
| Number of events/mL | % of the total labeled control | |||||||
|---|---|---|---|---|---|---|---|---|
| Total labeled events | Active (DCFDA+ and PI-) | Damaged (DCFDA+ and PI+) | Permeabilized (DCFDA- and PI+) | Total labeled events | Active (DCFDA+ and PI-) | Damaged (DCFDA+ and PI+) | Permeabilized (DCFDA- and PI+) | |
| Control | 1.93E + 07 ± 5.25E + 06 | 1.40E + 07 ± 5.60E + 06 | 6.19E + 05 ± 2.68E + 05 | 4.72E + 06 ± 1.92E + 06 | 100.00 | 72.36 | 3.21 | 24.44 |
| 5 min low pressure | 1.27E + 07 ± 5.93E + 06 | 1.34E + 0 ± 9.11E + 05 | 2.09E + 05 ± 1.34E + 05 | 1.12E + 07 ± 6.10E + 06 | 65.87 | 6.95 | 1.08 | 57.84 |
| 15 min low pressure | 1.65E + 07 ± 6.99E + 06 | 1.72E + 06 ± 1.60E + 06 | 1.97E + 05 ± 1.63E + 05 | 1.45E + 07 ± 6.72E + 06 | 85.27 | 8.92 | 1.02 | 75.33 |
| 5 min O2 | 6.65E + 06 ± 5.16E + 06 | 8.01E + 05 ± 6.20E + 05 | 6.11E + 04 ± 4.67E + 04 | 5.79E + 06 ± 4.64E + 06 | 34.43 | 4.14 | 0.32 | 29.97 |
| 15 min O2 | 2.26E + 06 ± 1.69E + 06 | 5.01E + 05 ± 4.88E + 05 | 3.73E + 04 ± 2.64E + 04 | 1.72E + 06 ± 1.35E + 06 | 11.68 | 2.59 | 0.19 | 8.89 |
| 5 min Ar | 4.61E + 06 ± 2.85E + 06 | 1.25E + 06 ± 9.05E + 05 | 1.11E + 05 ± 1.08E + 05 | 3.25E + 06 ± 1.92E + 06 | 23.86 | 6.48 | 0.58 | 16.80 |
| 15 min Ar | 2.01E + 06 ± 1.18E + 06 | 5.76E + 05 ± 4.88E + 05 | 4.58E + 04 ± 2.30E + 04 | 1.39E + 06 ± 7.59E + 05 | 10.43 | 2.98 | 0.24 | 7.21 |
| 5 min N2 | 1.93E + 07 ± 5.25E + 06 | 1.40E + 07 ± 5.60E + 06 | 1.93E + 07 ± 5.25E + 06 | 1.93E + 07 ± 5.25E + 06 | 54.57 | 4.91 | 0.44 | 49.22 |
| 15 min N2 | 2.43E + 07 ± 2.50E + 06 | 6.45E + 05 ± 1.14E + 06 | 4.36E + 04 ± 3.28E + 04 | 1.74E + 06 ± 1.41E + 06 | 12.58 | 3.34 | 0.23 | 9.01 |
Density of Staphylococcus aureus population determined by CLSM with DCFDA and PI after low pressure for 5 min, O2, Ar, and N2 NTP treatments for 5 and 120 min (events/mm2).
| Number of events (detected for 1 mm2) | % of the total labeled control | |||||||
|---|---|---|---|---|---|---|---|---|
| Total labeled events | Active (DCFDA+ and PI-) | Damaged (DCFDA+ and PI+) | Permeabilized (DCFDA- and PI+) | Total labeled events | Active (DCFDA+ and PI-) | Damaged (DCFDA+ and PI+) | Permeabilized (DCFDA- and PI+) | |
| Control | 7.69E + 04 | 4.99E + 04 | 1.75E + 04 | 9.52E + 03 | 100.00 | 64.85 | 22.72 | 12.37 |
| 5 min low pressure | 1.09E + 04 | 8.07E + 03 | 1.02E + 03 | 1.94E + 03 | 14.19 | 10.50 | 1.33 | 2.52 |
| 5 min O2 | 1.61E + 04 | 7.45E + 03 | 2.27E + 03 | 6.20E + 03 | 20.98 | 9.69 | 2.96 | 8.07 |
| 5 min Ar | 3.37E + 03 | 2.40E + 03 | 7.05E + 02 | 2.69E + 02 | 4.39 | 3.12 | 0.92 | 0.35 |
| 5 min N2 | 2.91E + 04 | 1.46E + 04 | 4.64E + 03 | 9.78E + 03 | 37.80 | 19.02 | 6.03 | 12.72 |
| 120 min O2 | 8.83E + 02 | 4.83E + 02 | 1.70E + 01 | 3.82E + 02 | 1.15 | 0.63 | 0.02 | 0.50 |
| 120 min Ar | 3.04E + 03 | 4.20E + 02 | 1.02E + 03 | 2.25E + 03 | 3.95 | 0.55 | 1.33 | 2.93 |
| 120 min N2 | 3.57E + 03 | 1.68E + 03 | 4.34E + 02 | 1.46E + 03 | 4.65 | 2.18 | 0.56 | 1.90 |